Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia

Publisher Website
Google Scholar
Abstract
Bone marrow samples from 8 children treated for acute lymphoblastic leukemia (ALL) were investigated at cessation of cytostatic treatment and during 18 months thereafter. The course of the percentage of lymphoid cells and characterization of these cells by means of monoclonal antibodies, peanut agglutinin (PNA) binding and S‐phase determination are shown. The percentage of lymphocytes rises in the first 1.5 months, followed by a non‐significant decline. The percentage of cells in S‐phase is higher at 0 months than at 6, 15 and 18 months. The percentage of T‐cells does not change significantly. In the first 1.5 months a sudden rise in the percentage of common‐ALL‐antigen (cALLA)‐positive lymphocytes occurs. The number of B‐cells rises to a peak at 6 months. PNA positivity increases to a maximum at 3 months and is correlated with positivity for markers of the B‐cell lineage. The percentages of B‐cells, cALLA‐positive, and PNA‐positive lymphocytes do not change significantly after they reach their maximum values and are still high at 18 months. Our results show that after cessation of chemotherapy for ALL a lymphoid cell regeneration occurs in the bone marrow consisting of cells of the B‐cell lineage; many of these are cALLA‐positive, but are discernible from their malignant counterparts by PNA‐positivity.